Welcome to airis PHARMA
Registered at USFDA with FEI # 3012071812, DUNS # 650864775 and inspected with zero 483.

Airis Pharma Overview
About Us airis PHARMA’s vision is to develop generic formulation products for the US market and other markets such as Europe, NZ-Aus, Turkey, and UK. The generic products range in complexity...

Research and Development
The generic product development ranges in complexity from oral solids to injectables with a focus on products that have a high entry barrier. The drug product development emphasizes on continuous quality at...

Analytical Quality Services
cGMP/GLP Services include the Raw Materials testing, Packaging materials testing, Drug Product exhibit and commercial batches testing, Stability Storage as per ICH conditions...
airis PHARMA – Vision
We are a passionate cohesive team committed to developing high quality generic drug products.
Latest News
April 2021: Received Approval of ANDA Aminocaproic acid oral solution, 0.25 g/mL
Copyright © 2021, airis PHARMA.com. All rights reserved.
Menu Title